ID: MRFR/HC/9314-HCR | August 2022 | Region: Global | 120 Pages
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Application
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porterβs Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Impact on Supply Chain
5.3.3. Regional Impact
5.3.4. Opportunity and Threat Analysis
6. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE
6.1. Overview
6.2. Swabs
6.2.1. Nasopharyngeal (NP) Swabs
6.2.2. Oropharyngeal (OP) Swabs
6.3. Viral Transport Media
6.4. Blood Collection Kits
6.5. Others
7. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET, BY APPLICATION
7.1. Overview
7.2. Diagnostics
7.3. Research
8. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET, BY BY END USER
8.1. Overview
8.2. Hospitals & Clinics
8.3. Diagnostic Centers
8.4. Others
9. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET, BY REGION
9.1. Overview
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. France
9.2.3. UK
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Middle East
9.4.2. Africa
9.4.3. Latin America
10. COMPANY LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Virology Specimen Collection Market
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Virology Specimen Collection Market
10.7. Key developments and Growth Strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial
10.8.1. Sales & Operating Income, 2020
10.8.2. Major Players R&D Expenditure. 2020
11. COMPANY PROFILES
11.1. Hardy Diagnostics
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Puritan Medical Products
11.3. COPAN Diagnostics
11.4. Becton, Dickinson and Company
11.5. Thermo Fisher Scientific, Inc.
11.6. BNTX Inc.
11.7. Formlabs
11.8. Medline Industries, Inc.
11.9. Laboratory Corporation of America Holdings
11.10. VIRCELL S.L.
11.11. Lucence Diagnostics Pte Ltd..
11.12. HiMedia Laboratories
12. APPENDIX
12.1. References
12.2. Related Reports
β
LIST OF TABLES
TABLE 1 GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SYNOPSIS, 2018β2030
TABLE 2 GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET ESTIMATES & FORECAST, 2018β2030 (USD MILLION)
TABLE 3 GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2018β2030 (USD MILLION)
TABLE 4 GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET, BY APPLICATION, 2018β2030 (USD MILLION)
TABLE 5 GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET, BY END USER, 2018β2030 (USD MILLION)
TABLE 6 NORTH AMERICA: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2018β2030 (USD MILLION)
TABLE 7 NORTH AMERICA: VIROLOGY SPECIMEN COLLECTION MARKET, BY APPLICATION, 2018β2030 (USD MILLION)
TABLE 8 NORTH AMERICA: VIROLOGY SPECIMEN COLLECTION MARKET, BY END USER, 2018β2030 (USD MILLION)
TABLE 9 US: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2018β2030 (USD MILLION)
TABLE 10 US: VIROLOGY SPECIMEN COLLECTION MARKET, BY APPLICATON, 2018β2030 (USD MILLION)
TABLE 11 US: VIROLOGY SPECIMEN COLLECTION MARKET, BY END USER, 2018β2030 (USD MILLION)
TABLE 12 CANADA: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2018β2030 (USD MILLION)
TABLE 13 CANADA: VIROLOGY SPECIMEN COLLECTION MARKET, BY APPLICATON, 2018β2030 (USD MILLION)
TABLE 14 CANADA: VIROLOGY SPECIMEN COLLECTION MARKET, BY END USER, 2018β2030 (USD MILLION)
TABLE 15 EUROPE: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2018β2030 (USD MILLION)
TABLE 16 EUROPE: VIROLOGY SPECIMEN COLLECTION MARKET, BY APPLICATON, 2018β2030 (USD MILLION)
TABLE 17 EUROPE: VIROLOGY SPECIMEN COLLECTION MARKET, BY END USER, 2018β2030 (USD MILLION)
TABLE 18 GERMANY: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2018β2030 (USD MILLION)
TABLE 19 GERMANY: VIROLOGY SPECIMEN COLLECTION MARKET, BY APPLICATON, 2018β2030 (USD MILLION)
TABLE 20 GERMANY: VIROLOGY SPECIMEN COLLECTION MARKET, BY END USER, 2018β2030 (USD MILLION)
TABLE 21 FRANCE: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2018β2030 (USD MILLION)
TABLE 22 FRANCE: VIROLOGY SPECIMEN COLLECTION MARKET, BY APPLICATON, 2018β2030 (USD MILLION)
TABLE 23 FRANCE: VIROLOGY SPECIMEN COLLECTION MARKET, BY END USER, 2018β2030 (USD MILLION)
TABLE 24 ITALY: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2018β2030 (USD MILLION)
TABLE 25 ITALY: VIROLOGY SPECIMEN COLLECTION MARKET, BY APPLICATON, 2018β2030 (USD MILLION)
TABLE 26 ITALY: VIROLOGY SPECIMEN COLLECTION MARKET, BY END USER, 2018β2030 (USD MILLION)
TABLE 27 SPAIN: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2018β2030 (USD MILLION)
TABLE 28 SPAIN: VIROLOGY SPECIMEN COLLECTION MARKET, BY APPLICATON, 2018β2030 (USD MILLION)
TABLE 29 SPAIN: VIROLOGY SPECIMEN COLLECTION MARKET, BY END USER, 2018β2030 (USD MILLION)
TABLE 30 UK: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2018β2030 (USD MILLION)
TABLE 31 UK: VIROLOGY SPECIMEN COLLECTION MARKET, BY APPLICATON, 2018β2030 (USD MILLION)
TABLE 32 UK: VIROLOGY SPECIMEN COLLECTION MARKET, BY END USER, 2018β2030 (USD MILLION)
TABLE 33 REST OF EUROPE: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2018β2030 (USD MILLION)
TABLE 34 REST OF EUROPE: VIROLOGY SPECIMEN COLLECTION MARKET, BY APPLICATON, 2018β2030 (USD MILLION)
TABLE 35 REST OF EUROPE: VIROLOGY SPECIMEN COLLECTION MARKET, BY END USER, 2018β2030 (USD MILLION)
TABLE 36 ASIA-PACIFIC: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2018β2030 (USD MILLION)
TABLE 37 ASIA-PACIFIC: VIROLOGY SPECIMEN COLLECTION MARKET, BY APPLICATON, 2018β2030 (USD MILLION)
TABLE 38 ASIA-PACIFIC: VIROLOGY SPECIMEN COLLECTION MARKET, BY END USER, 2018β2030 (USD MILLION)
TABLE 39 JAPAN: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2018β2030 (USD MILLION)
TABLE 40 JAPAN: VIROLOGY SPECIMEN COLLECTION MARKET, BY APPLICATON, 2018β2030 (USD MILLION)
TABLE 41 JAPAN: VIROLOGY SPECIMEN COLLECTION MARKET, BY END USER, 2018β2030 (USD MILLION)
TABLE 42 CHINA: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2018β2030 (USD MILLION)
TABLE 43 CHINA: VIROLOGY SPECIMEN COLLECTION MARKET, BY APPLICATON, 2018β2030 (USD MILLION)
TABLE 44 CHINA: VIROLOGY SPECIMEN COLLECTION MARKET, BY END USER, 2018β2030 (USD MILLION)
TABLE 45 INDIA: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2018β2030 (USD MILLION)
TABLE 46 INDIA: VIROLOGY SPECIMEN COLLECTION MARKET, BY APPLICATON, 2018β2030 (USD MILLION)
TABLE 47 INDIA: VIROLOGY SPECIMEN COLLECTION MARKET, BY END USER, 2018β2030 (USD MILLION)
TABLE 48 AUSTRALIA: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2018β2030 (USD MILLION)
TABLE 49 AUSTRALIA: VIROLOGY SPECIMEN COLLECTION MARKET, BY APPLICATON, 2018β2030 (USD MILLION)
TABLE 50 AUSTRALIA: VIROLOGY SPECIMEN COLLECTION MARKET, BY END USER, 2018β2030 (USD MILLION)
TABLE 51 SOUTH KOREA: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2018β2030 (USD MILLION)
TABLE 52 SOUTH KOREA: VIROLOGY SPECIMEN COLLECTION MARKET, BY APPLICATON, 2018β2030 (USD MILLION)
TABLE 53 SOUTH KOREA: VIROLOGY SPECIMEN COLLECTION MARKET, BY END USER, 2018β2030 (USD MILLION)
TABLE 54 REST OF ASIA-PACIFIC: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2018β2030 (USD MILLION)
TABLE 55 REST OF ASIA-PACIFIC: VIROLOGY SPECIMEN COLLECTION MARKET, BY APPLICATON, 2018β2030 (USD MILLION)
TABLE 56 REST OF ASIA-PACIFIC: VIROLOGY SPECIMEN COLLECTION MARKET, BY END USER, 2018β2030 (USD MILLION)
TABLE 57 REST OF THE WORLD: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2018β2030 (USD MILLION)
TABLE 58 REST OF THE WORLD: VIROLOGY SPECIMEN COLLECTION MARKET, BY APPLICATON, 2018β2030 (USD MILLION)
TABLE 59 REST OF THE WORLD: VIROLOGY SPECIMEN COLLECTION MARKET, BY END USER, 2018β2030 (USD MILLION)
TABLE 60 MIDDLE EAST: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2018β2030 (USD MILLION)
TABLE 61 MIDDLE EAST: VIROLOGY SPECIMEN COLLECTION MARKET, BY APPLICATON, 2018β2030 (USD MILLION)
TABLE 62 MIDDLE EAST: VIROLOGY SPECIMEN COLLECTION MARKET, BY END USER, 2018β2030 (USD MILLION)
TABLE 63 AFRICA: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2018β2030 (USD MILLION)
TABLE 64 AFRICA: VIROLOGY SPECIMEN COLLECTION MARKET, BY APPLICATON, 2018β2030 (USD MILLION)
TABLE 65 AFRICA: VIROLOGY SPECIMEN COLLECTION MARKET, BY END USER, 2018β2030 (USD MILLION)
TABLE 66 LATIN AMERICA: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2018β2030 (USD MILLION)
TABLE 67 LATIN AMERICA: VIROLOGY SPECIMEN COLLECTION MARKET, BY APPLICATON, 2018β2030 (USD MILLION)
TABLE 68 LATIN AMERICA: VIROLOGY SPECIMEN COLLECTION MARKET, BY END USER, 2018β2030 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET
FIGURE 4 GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SHARE (%), BY PRODUCT TYPE, 2020
FIGURE 5 GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SHARE (%), BY APPLICATON, 2020
FIGURE 6 GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SHARE (%), BY END USER, 2020
FIGURE 7 GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SHARE (%), BY REGION, 2020
FIGURE 8 NORTH AMERICA: VIROLOGY SPECIMEN COLLECTION MARKET SHARE (%), BY REGION, 2020
FIGURE 9 EUROPE: VIROLOGY SPECIMEN COLLECTION MARKET SHARE (%), BY REGION, 2020
FIGURE 10 ASIA-PACIFIC: VIROLOGY SPECIMEN COLLECTION MARKET SHARE (%), BY REGION, 2020
FIGURE 11 REST OF THE WORLD: VIROLOGY SPECIMEN COLLECTION MARKET SHARE (%), BY REGION, 2020
FIGURE 12 GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET: COMPANY SHARE ANALYSIS (%), 2020
FIGURE 13 HARDY DIAGNOSTICS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 HARDY DIAGNOSTICS: SWOT ANALYSIS
FIGURE 15 PURITAN MEDICAL PRODUCTS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 PURITAN MEDICAL PRODUCTS: SWOT ANALYSIS
FIGURE 17 COPAN DIAGNOSTICS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 COPAN DIAGNOSTICS: SWOT ANALYSIS
FIGURE 19 BECTON, DICKINSON, AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 BECTON, DICKINSON, AND COMPANY: SWOT ANALYSIS
FIGURE 21 THERMO FISHER SCIENTIFIC, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 THERMO FISHER SCIENTIFIC, INC.: SWOT ANALYSIS
FIGURE 23 BNTX INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 BNTX INC.: SWOT ANALYSIS
FIGURE 25 FORMLABS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 FORMLABS: SWOT ANALYSIS
FIGURE 27 LABORATORY CORPORATION OF AMERICA HOLDINGS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 LABORATORY CORPORATION OF AMERICA HOLDINGS: SWOT ANALYSIS
FIGURE 29 VIRCELL S.L.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 VIRCELL S.L.: SWOT ANALYSIS
FIGURE 31 LUCENCE DIAGNOSTICS PTE LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 LUCENCE DIAGNOSTICS PTE LTD.: SWOT ANALYSIS
FIGURE 33 HIMEDIA LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 HIMEDIA LABORATORIES: SWOT ANALYSIS
$8,974 Million
5.3%
North America
2022-2030
The global virology specimen collection market size is projected to be worth ~USD 8,974 million by 2030, registering a CAGR of ~5.3% during the forecast period (2021 - 2030)
Specimen collection is the process of obtaining substances for laboratory analysis or near-patient testing. The sample collection kit includes the vitals and reagents used in collecting samples and shipping them to the laboratory, where the testing services will be performed. There is a rise in the demand for virology specimen collection kits due to the increasing incidence of various viral diseases, COVID-19 outbreak globally, and approval of new and advanced detection tests by authorities. In May 2020, Everlywell, Inc. received an emergency use authorization (EUA) from the Food and Drug Administration (FDA) for the COVID-19 test sample collection kit. The product is a standalone, at-home nasal swab sample collection kit with a saline-filled tube that can be sent to specified labs for subsequent COVID-19 diagnostic testing. This, in turn, has positively impacted the virology specimen collection market.
COVID-19 Analysis
Market Dynamics
Drivers
Market Restraints
Market Opportunities
Value Chain Analysis
The global virology specimen collection market is projected to exhibit significant growth during the forecast period. This is attributed to the rising prevalence of viral diseases, the growing number of blood donations, and government approval for new and advanced detection tests. In addition, a surge in demand for sample collection kits across the globe due to the COVID-19 outbreak has further contributed to the market growth. The value chain analysis for the market is comprised of five major components, which start with research & product development, followed by product manufacturing, distribution & sales, and end with post-marketing surveillance. In the research and product development stage, new models and designs are introduced to make the products better and more effective, with the major focus of manufacturers on designing the comfort of the patients. The manufacturing process begins with the assembly of raw materials. Manufacturing is a quick process followed by testing for safety, accuracy, and comfort. Distribution & sales play a critical role in the market value chain analysis. It consists of intermediaries, direct selling channels, and others. Post-sales monitoring plays a significant role in this market. The follow-up stage gives an idea about the sales of the products and helps understand any limitations or feedback from the users.
Segment Overview
By Product Type
By Application
By End User
Regional Analysis
The virology specimen collection market based on the region has been segmented into North America, Europe, Asia-Pacific, and the Rest of the World.
North America: According to the US Food and Drug Administration (FDA), in April 2020, Laboratory Corporation of America (LabCorp) is the first diagnostic test developer for an at-home specimen collection kit for COVID-19. This is anticipated to boost the virology specimen collection market across the region during the forecast period.
Europe: According to the World Health Organization (WHO), January 2020 report, the World Health Organization (WHO), and the European Centre for Disease Prevention and Control (ECDC) are working closely for identifying the laboratory needs and capacities in the European region. Thus, sample collection kits are required for laboratory tests and detection due to the increasing incidence of viral diseases and a rise in the number of confirmed cases of COVID-19. This is expected to drive the virology specimen collection market growth.
Asia-Pacific: Due to the outbreak of COVID-19 cases, the Asian Development Bank (ADB), in April 2021, announced a USD 31.6 billion aid package for the Asia and the Pacific region in 2020 to tackle the outbreak and support green and sustainable green recovery. Thus, an increase in government funding is expected to drive the virology specimen collection market growth.
Middle East & Africa: The Middle East & Africa region is more under proper infrastructural development and technological advancements. This, in turn, leads to low development in the healthcare industry, which reduces the overall sample collection kits production in the market. A rise in development and technology is expected to drive the virology specimen collection market growth.
Competitive Landscape
The key industry players are adopting various business strategies such as significant investments in R&D activities to increase their market presence and expand their product portfolio, driving the Virology Specimen Collection market. In addition, the market players are adopting several strategic initiatives such as new product launches, mergers & acquisitions, contractual agreements, increasing investments, and collaboration with other players to expand their global footprint. For instance, in March 2020, Becton, Dickinson and Company (BD) (U.S.) and BioMedomics (U.S.), a clinical diagnostics company, announced the launch of a new point-of-care serology test. The test is utilized to detect antibodies in the blood to confirm current or past exposure to COVID-19 within 15 minutes. The new test, developed and manufactured by BioMedomics, is available through BD and distributed exclusively by Henry Schein, Inc. to health care providers throughout the United States.
List of companies covered in this report:
Recent Developments
Report Overview
The study covers the existing short-term and long-term market effects. It helps decision-makers to draught short-term and long-term business plans by region. The report covers major regions in North America, Europe, Asia-Pacific, and the Rest of the World. The report analyzes market drivers, restraints, opportunities, challenges, Porter's five forces, value chain, and impact of COVID-19 on the market.
Study Objectives
Market Segmentation:
Global Virology Specimen Collection Market, By Product Type
Global Virology Specimen Collection Market, By Application
Global Virology Specimen Collection Market, By End User
Global Virology Specimen Collection Market, By Region
Intended Audience
Report Attribute/Metric | Details |
---|---|
Market Size | 2030: ~USD 9,904 Million |
CAGR | ~6.8% |
Base Year | 2020 |
Forecast Period | 2021β2030 |
Historical Data | 2018 & 2019 |
Forecast Units | Value (USD Million) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Product Type, Application, and End User |
Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World |
Key Vendors | Thermo Fisher Scientific, Inc. (US), Hardy Diagnostics (US), BNTX Inc. (Germany), Formlabs (US), Medline Industries, Inc. (US), HiMedia Laboratories (India), VIRCELL S.L. (Spain), Puritan Medical Products (US), COPAN Diagnostics (US), Becton, Dickinson, and Company (US), Laboratory Corporation of America Holdings (US), Lucence Diagnostics Pte Ltd. (US). |
Key Market Opportunities | Rise in demand for rapid diagnostic tests. |
Key Market Drivers | β’ Approval of specimen collection kits by regulatory authorities. β’ Large volume and usage rate of Swabs. β’ Increase in government funding. β’ Rise in the demand for at-home kits for reducing the risk of virus transmission |